Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

NCT03787056 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT03787056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03787056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2018
Completion date
January 4, 2028
Enrollment
410 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell lymphoma, bladder cancer, breast cancer, cancer, colorectal cancer, endometrial cancer, esophageal cancer, gastric cancer, glioblastoma, head and neck cancer, hepatocellular cancer, lung cancer, melanoma, ovarian cancer, pancreatic cancer, prostate cancer, renal cancer